Cogent Biosciences, Inc. Common Stock (NASDAQ: COGT) last traded at $28.37, down 4.73% on the session. The quote above updates while this page is open; the figures below are drawn from Cogent Biosciences, Inc. Common Stock’s own filings and are restated only when a new one is published.
Cogent Biosciences, Inc. Common Stock trades on NASDAQ under the ticker COGT. Its market capitalisation is $4.92 billion.
Valuation measures for Cogent Biosciences, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $4.92B |
|---|---|
| Enterprise value | $5.04B |
| Price / book | 9.25 |
| Beta | 2.58 |
Trailing-twelve-month figures tagged in Cogent Biosciences, Inc. Common Stock's XBRL filings with the SEC.
| Net income (TTM) |
|---|
| -$377.18M |
| EPS (TTM) | -$2.16 |
|---|
| Return on equity | -70.85% |
|---|
| Cash | $181.17M |
|---|
Range and volume for COGT over the past 52 weeks.
| 52-week high | $43.73 |
|---|---|
| 52-week low | $13.78 |
| Volume | 1.25M |
| Average volume | 1.90M |
| Previous close | $29.78 |
Invest a chosen dollar amount in Cogent Biosciences, Inc. Common Stock with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell COGT.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.